Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
BMJ Case Reports|January 30, 2026
Necrotising fasciitis in chronic lymphocytic leukaemia: a diagnostic challenge, management and learning pointsArthur Chen Wun Tan, Eun Young Han, Ezanul Harriz Abd Wahab, et al.Molecular and Cellular Biology|October 1, 2004
Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cellsMelany Jackson, Anna Krassowska, Nick Gilbert, et al.Stem Cells and Development|November 14, 2014
Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1Gillian A Horne, Helen J S Stewart, Jacqueline Dickson, et al.Clinical Medicine (London, England)|March 17, 2021
Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workersAlyss V Robinson, Gary Weaving, Barbara J Philips, et al.Blood Cancer Journal|July 4, 2024
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing dataRichard Norris, John Jones, Erika Mancini, et al.Hematological Oncology|May 11, 2022
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myelomaAlessandro Agnarelli, Simon Mitchell, Gillian Caalim, et al.Scientific Reports|April 23, 2015
The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cellsBasudev Chowdhury, Andrew McGovern, Yi Cui, et al.Clinical Medicine (London, England)|July 23, 2020
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?Eleni E Ladikou, Helena Sivaloganathan, Kate M Milne, et al.Leukemia Research|January 18, 2014
Elacytarabine in relapsed/refractory acute myeloid leukaemia: an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profileSteven Knapper, Timothy Chevassut, Rafael Duarte, et al.British Journal of Anaesthesia|March 8, 2022
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial)Robert Kong, Nevil Hutchinson, Andrew Hill, et al.Pageof 4